Kenza Health Hub logoGet Started
31 August 2026Chapter 3: Gastrointestinal disordersPDF page 118

Amoebiasis

Full paraphrased clinical guide to intestinal amoebiasis, amoebic liver abscess, diagnosis, treatment, and follow-up.

This guide supports clinical education and care navigation. It does not replace bedside judgement, emergency care, specialist advice, or local treatment protocol.

Seek urgent care

  • Bloody or mucus diarrhoea with dehydration, severe abdominal pain, fever, altered mental status, or inability to drink.
  • Right upper abdominal pain, tender enlarged liver, jaundice, respiratory symptoms, or suspected liver abscess.
  • Symptoms not improving after appropriate dysentery treatment, especially after shigellosis treatment failure.

Overview

Amoebiasis is a parasitic infection caused by Entamoeba histolytica and transmitted by the faecal-oral route through contaminated food or water.

Many carriers have no symptoms. In a smaller proportion, the parasite invades the colon and causes amoebic dysentery.

The parasite can also spread through the bloodstream and form abscesses, most commonly in the liver.

Amoebic dysentery

  • Diarrhoea may contain red blood and mucus.
  • Abdominal pain and tenesmus can occur.
  • Fever is absent or moderate in many cases.
  • Assess for dehydration and nutritional risk.

Amoebic liver abscess

  • Consider liver abscess with fever, right upper abdominal pain, tender enlarged liver, or symptoms that suggest extra-intestinal spread.
  • Respiratory discomfort or referred shoulder pain can occur when the abscess irritates nearby structures.
  • Point-of-care ultrasound can support diagnosis only when performed and interpreted by trained clinicians.

Investigations

  • For amoebic dysentery, confirmation requires identification of mobile Entamoeba histolytica trophozoites in a fresh stool sample.
  • Finding cysts alone should not lead to amoebiasis treatment because many carriers are asymptomatic and cyst microscopy may not prove invasive disease.
  • In dysentery, shigellosis is more common and should be considered first in many settings.
  • For amoebic liver abscess, indirect haemagglutination or ELISA may support diagnosis when available.
  • Point-of-care ultrasound can help evaluate liver and spleen lesions only when performed and interpreted by trained clinicians, with expert support when needed.

Treatment

  • Treat dehydration with ORS or IV fluids according to severity and maintain nutrition.
  • If laboratory confirmation is unavailable, first-line treatment for dysentery is shigellosis treatment. Treat amoebiasis if correct shigellosis treatment has been ineffective.
  • Liver abscess requires clinical follow-up and imaging or referral where available. Drainage is reserved for selected situations, such as diagnostic uncertainty, poor response, high rupture risk, or specialist advice.
  • Avoid alcohol during nitroimidazole treatment and check contraindications, pregnancy status, interactions, and local protocol.
Amoebic dysentery
MedicineDose and duration
Tinidazole POChildren: 50 mg/kg once daily for 3 days, maximum 2 g/day. Adults: 2 g once daily for 3 days.
Metronidazole POChildren: 15 mg/kg three times daily for 5 days. Adults: 500 mg three times daily for 5 days.
Amoebic liver abscess
MedicineDose and duration
Tinidazole POSame dose as dysentery, for 5 days.
Metronidazole POSame dose as dysentery, for 5 to 10 days.

Prevention, complications, and handover

  • Prevention depends on safe water, sanitation, hand hygiene, safe food handling, and avoiding faecal contamination of food and water.
  • Complications include severe dehydration, colitis, perforation, liver abscess rupture, pleuropulmonary extension, secondary bacterial infection, and sepsis.
  • Refer urgently for suspected liver abscess with severe illness, jaundice, respiratory symptoms, peritonitis signs, persistent fever, shock, or failure to improve.
  • Handover should include stool findings, dehydration status, prior shigellosis treatment and response, stool microscopy result, liver findings, ultrasound/serology results, medicine regimen, ability to drink, complications, and follow-up plan.

Medicines in this guide

Source

MSF Clinical guidelines - Diagnosis and treatment manual (December 2024)

This page is a paraphrased clinician-oriented guide derived from the source topic on PDF page 118. Medicine-specific details should be checked against local protocol and the linked drug-information pages.